The use of bevacizumab and ranibizumab for branch retinal vein occlusion in medicare beneficiaries.
about
The use of bevacizumab and ranibizumab for branch retinal vein occlusion in medicare beneficiaries.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
The use of bevacizumab and ran ...... ion in medicare beneficiaries.
@en
The use of bevacizumab and ran ...... ion in medicare beneficiaries.
@nl
type
label
The use of bevacizumab and ran ...... ion in medicare beneficiaries.
@en
The use of bevacizumab and ran ...... ion in medicare beneficiaries.
@nl
prefLabel
The use of bevacizumab and ran ...... ion in medicare beneficiaries.
@en
The use of bevacizumab and ran ...... ion in medicare beneficiaries.
@nl
P2093
P2860
P1476
The use of bevacizumab and ran ...... sion in medicare beneficiaries
@en
P2093
Anne L Coleman
Annie M Wu
Connie M Wu
Paul B Greenberg
P2860
P304
P356
10.1016/J.AJOC.2018.06.005
P577
2018-06-19T00:00:00Z